Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_assertion description "[The aim was to explore the utility for staging and prognostic impact of carcinoembryonic antigen (CEA), cytokeratin 20 (CK20), guanylyl cyclase C (GCC), CUB (complement protein subcomponents C1r/C1s, urchin embryonic growth factor, and bone morphogenic protein 1) containing domain protein 1 (CDCP1) and mucin 2 (MUC2) mRNA levels in mesenteric lymph nodes of colorectal cancer (CRC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_assertion evidence source_evidence_literature NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_assertion SIO_000772 21618511 NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_assertion wasDerivedFrom befree-2016 NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_assertion wasGeneratedBy ECO_0000203 NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.
- befree-2016 importedOn "2016-02-19" NP897377.RA5LbVm3nqgeCg8OcuFY3PItG2BRMojVFW0ZHTEKLS8JA130_provenance.